Collegium

Collegium Pharmaceutical develops abuse-deterrent drugs like Xtampza ER and Nucynta using its DETERx platform to treat chronic pain and other diseases.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2015
Stage of Initial Investment
Series D
Initial Investment Year
2015
Collegium Portco Hover Image2